Healthcare provider profile · identity verified

Marvin Lee Ray, MD

Internal Medicine · MIDDLETOWN, OH · NPI 1164402103

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	449	180
Amlodipine Besylate	Amlodipine Besylate	365	129
Gabapentin	Gabapentin	297	78
Lisinopril	Lisinopril	270	104
Levothyroxine Sodium	Levothyroxine Sodium	266	97
Alprazolam	Alprazolam	255	42
Lorazepam	Lorazepam	249	53
Simvastatin	Simvastatin	230	71
Metformin Hcl	Metformin Hcl	229	83
Omeprazole	Omeprazole	219	85
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	183	63
Tramadol Hcl	Tramadol Hcl	158	41
Citalopram Hbr	Citalopram Hydrobromide	156	40
Clonazepam	Clonazepam	150	23
Albuterol Sulfate Hfa	Albuterol Sulfate	140	52
Meloxicam	Meloxicam	128	41
Metoprolol Succinate	Metoprolol Succinate	126	52
Metoprolol Tartrate	Metoprolol Tartrate	122	47
Losartan Potassium	Losartan Potassium	120	54
Trazodone Hcl	Trazodone Hcl	112	37
Montelukast Sodium	Montelukast Sodium	109	36
Furosemide	Furosemide	108	47
Hydrochlorothiazide	Hydrochlorothiazide	105	44
Tizanidine Hcl	Tizanidine Hcl	104	39
Pantoprazole Sodium	Pantoprazole Sodium	95	43
Tamsulosin Hcl	Tamsulosin Hcl	87	38
Sertraline Hcl	Sertraline Hcl	85	27
Nabumetone	Nabumetone	73	39
Promethazine Hcl	Promethazine Hcl	69	18
Esomeprazole Magnesium	Esomeprazole Magnesium	67	25
Escitalopram Oxalate	Escitalopram Oxalate	65	22
Zolpidem Tartrate	Zolpidem Tartrate	65	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	64	18
Rosuvastatin Calcium	Rosuvastatin Calcium	64	25
Carvedilol	Carvedilol	63	26
Clopidogrel	Clopidogrel Bisulfate	59	26
Metformin Hcl Er	Metformin Hcl	58	21
Allopurinol	Allopurinol	57	26
Synthroid	Levothyroxine Sodium	55	23
Diazepam	Diazepam	52	suppressed
Duloxetine Hcl	Duloxetine Hcl	52	21
Glimepiride	Glimepiride	52	25
Atenolol	Atenolol	50	19
Cefuroxime	Cefuroxime Axetil	50	48
Pregabalin	Pregabalin	50	15
Famotidine	Famotidine	48	21
Eliquis	Apixaban	47	22
Fluticasone Propionate	Fluticasone Propionate	46	24
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	46	12
Celecoxib	Celecoxib	45	16
Potassium Chloride	Potassium Chloride	42	20
Pravastatin Sodium	Pravastatin Sodium	42	17
Temazepam	Temazepam	42	suppressed
Ezetimibe	Ezetimibe	39	15
Nifedipine Er	Nifedipine	38	14
Bupropion Xl	Bupropion Hcl	37	16
Mirtazapine	Mirtazapine	37	14
Buspirone Hcl	Buspirone Hcl	36	14
Hydroxyzine Hcl	Hydroxyzine Hcl	36	22
Methocarbamol	Methocarbamol	35	15
Donepezil Hcl	Donepezil Hcl	34	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	14
Venlafaxine Hcl Er	Venlafaxine Hcl	34	15
Prednisone	Prednisone	32	24
Doxycycline Hyclate	Doxycycline Hyclate	31	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	12
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	12
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Klor-Con M20	Potassium Chloride	29	13
Januvia	Sitagliptin Phosphate	28	suppressed
Torsemide	Torsemide	28	11
Farxiga	Dapagliflozin Propanediol	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	22
Spironolactone	Spironolactone	27	suppressed
Valsartan	Valsartan	27	suppressed
Jardiance	Empagliflozin	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Risperidone	Risperidone	26	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	12
Ibuprofen	Ibuprofen	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Azithromycin	Azithromycin	23	22
Baclofen	Baclofen	23	suppressed
Finasteride	Finasteride	23	12
Cephalexin	Cephalexin	22	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	11
Carisoprodol	Carisoprodol	21	suppressed
Glipizide	Glipizide	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Sotalol	Sotalol Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	15
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Fluconazole	Fluconazole	16	14
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Ramipril	Ramipril	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	11
Ozempic	Semaglutide	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	13
Warfarin Sodium	Warfarin Sodium	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	11
Methylprednisolone	Methylprednisolone	13	12
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lactulose	Lactulose	12	suppressed
Nadolol	Nadolol	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error